Elastrin Therapeutics Inc. is a biotech start-up with a mission to improve quality of life by restoring damaged hardened tissue to healthy reliance. Elastrin Therapeutics was founded by Prof. Naren Vyavahare and Dr. Charles Rice of Clemson University, South Carolina, Douglas Mulhall and Dr. Mirko Stange of Silversky Life Sciences GmbH, Duesseldorf, Germany.
Ando ApS has supported Elastrin Therapeutics Inc., USA in accelerating the funding process by providing recommendations on the next value-generating nonclinical/ CMC development steps of their innovative treatment concept of medial vascular calcification
User Rating: 0 / 5
